Oppenheimer Reiterates Outperform Rating on Gilead Sciences (GILD) Following CMO Meeting
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh reiterated an Outperform rating and $115.00 price target on Gilead Sciences (NASDAQ: GILD) after meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
